Mike Nurmohamed

PROF.DR.

20082019
If you made any changes in Pure these will be visible here soon.

Research Output 2008 2019

Filter
Article
2016

Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study

Moens, S. J. B., van der Valk, F. M., Strang, A. C., Kroon, J., Smits, L. P., Kneepkens, E. L., Verberne, H. J., van Buul, J. D., Nurmohamed, MT. & Stroes, E. S. G., 21 May 2016, In : Arthritis Research & Therapy. 18, 115.

Research output: Contribution to journalArticleAcademicpeer-review

2015

Cardiovascular comorbidity in rheumatic diseases

Nurmohamed, M. T., Heslinga, M. & Kitas, G. D., 2015, In : Nature Reviews Rheumatology. 11, 12, p. 693-704

Research output: Contribution to journalArticleAcademicpeer-review

Cardiovascular Disease-related Hospital Admissions of Patients with Inflammatory Arthritis

Ursum, J., Nielen, M. M. J., Twisk, J. W. R., Peters, M. J. L., Schellevis, F. G., Nurmohamed, M. T. & Korevaar, J. C., 2015, In : Journal of Rheumatology. 42, 2, p. 188-192

Research output: Contribution to journalArticleAcademicpeer-review

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation

Heslinga, S. C., van den Oever, I. A., van Sijl, A. M., Peters, M. J., van der Horst-Bruinsma, I. E., Smulders, Y. M. & Nurmohamed, M. T., 2015, In : BMC Musculoskeletal Disorders. 16, 80.

Research output: Contribution to journalArticleAcademicpeer-review

Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity

Plasencia, C., Kneepkens, E. L., Wolbink, G., Krieckaert, C. L. M., Turk, S., Navarro-Compan, V., L'Ami, M., Nurmohamed, M. T., van der Horst-Bruinsma, I. E., Jurado, T., Diego, C., Bonilla, G., Villalba, A., Peiteado, D., Nuno, L., van der Kleij, D., Rispens, T., Martin-Mola, E., Balsa, A. & Pascual-Salcedo, D., 2015, In : Journal of Rheumatology. 42, 9, p. 1638-1646

Research output: Contribution to journalArticleAcademicpeer-review

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

Bykerk, V. P., Ostor, A. J. K., Alvaro-Gracia, J., Pavelka, K., Ivorra, J. A. R., Graninger, W., Bensen, W., Nurmohamed, M. T., Krause, A., Bernasconi, C., Aassi, M. & Sibilia, J., 2015, In : Clinical Rheumatology. 34, 3, p. 563-571

Research output: Contribution to journalArticleAcademicpeer-review

C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis

Claushuis, T. A. M., de Vries, M. K., van der Weijden, M. A. C., Visman, I. M., Nurmohamed, M. T., Twisk, J. W. R., van der Horst-Bruinsma, I. E. & Crusius, J. B. A., 2015, In : Clinical and Experimental Rheumatology. 33, 2, p. 159-165

Research output: Contribution to journalArticleAcademicpeer-review

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

de Jong, T. D., Vosslamber, S., Blits, M., Wolbink, G., Nurmohamed, M. T., van der Laken, C. J., Jansen, G., Voskuyl, A. E. & Verweij, C. L., 2015, In : Arthritis Research & Therapy. 17, 78.

Research output: Contribution to journalArticleAcademicpeer-review

Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up

Kneepkens, E. L., Wei, J. C. C., Nurmohamed, M. T., Yeo, K. J., Chen, C. Y., van der Horst-Bruinsma, I. E., van der Kleij, D., Rispens, T., Wolbink, G. & Krieckaert, C. L. M., 2015, In : Annals of the Rheumatic Diseases. 74, 2, p. 396-401

Research output: Contribution to journalArticleAcademicpeer-review

Key findings towards optimising adalimumab treatment: the concentration-effect curve

Pouw, M. F., Krieckaert, C. L., Nurmohamed, M. T., van der Kleij, D., Aarden, L., Rispens, T. & Wolbink, G., 2015, In : Annals of the Rheumatic Diseases. 74, 3, p. 513-518

Research output: Contribution to journalArticleAcademicpeer-review

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

Nurmohamed, M. T., Bao, Y., Signorovitch, J., Trahey, A., Mulani, P. & Furst, D. E., 2015, In : RMD Open. 2015, 1, e000080.

Research output: Contribution to journalArticleAcademicpeer-review

Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up

Kneepkens, E. L., Krieckaert, C. L. M., van der Kleij, D., Nurmohamed, M. T., van der Horst-Bruinsma, I. E., Rispens, T. & Wolbink, G. J., 2015, In : Annals of the Rheumatic Diseases. 74, 10, p. 1825-1829

Research output: Contribution to journalArticleAcademicpeer-review

Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

Krieckaert, C. L. M., Nair, S. C., Nurmohamed, M. T., van Dongen, C. J. J., Lems, W. F., Lafeber, F. P. J. G., Bijlsma, J. W. J., Koffijberg, H., Wolbink, G. & Welsing, P. M. J., 2015, In : Annals of the Rheumatic Diseases. 74, 2, p. 361-368

Research output: Contribution to journalArticleAcademicpeer-review

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

Nusslein, H. G., Alten, R., Galeazzi, M., Lorenz, H. M., Nurmohamed, M. T., Bensen, W. G., Burmester, G. R., Peter, H. H., Pavelka, K., Chartier, M., Poncet, C., Rauch, C. & Le Bars, M., 2015, In : BMC Musculoskeletal Disorders. 16, 176.

Research output: Contribution to journalArticleAcademicpeer-review

Reduction of Inflammation Drives Lipid Changes in Ankylosing Spondylitis

Heslinga, S. C., Peters, M. J., ter Wee, M. M., van der Horst-Bruinsma, I. E., van Sijl, A. M., Smulders, Y. M. & Nurmohamed, M. T., 2015, In : Journal of Rheumatology. 42, 10, p. 1842-1845

Research output: Contribution to journalArticleAcademicpeer-review

Reumatoïde artritis risicofactor hart- en vaatziekten

Nurmohamed, M. T., 2015, In : Tijdschrift voor praktijkondersteuning. 10, 5, p. 158-163

Research output: Contribution to journalArticleProfessional

Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients

Bloem, K., van Leeuwen, A., Verbeek, G., Nurmohamed, M. T., Wolbink, G. J., van der Kleij, D. & Rispens, T., 2015, In : Journal of Immunological Methods. 418, p. 29-38

Research output: Contribution to journalArticleAcademicpeer-review

Treat to Target in Rheumatoid Arthritis: Good for the Joints as Well as the Heart?

Nurmohamed, M. T., 2015, In : Arthritis & rheumatology. 67, 6, p. 1412-1415

Research output: Contribution to journalArticleAcademicpeer-review

Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review

Heslinga, S. C., van Sijl, A. M., de Boer, K., Van Halm, V. P. & Nurmohamed, M., 2015, In : Current Medicinal Chemistry. 22, 16, p. 1892-1902

Research output: Contribution to journalArticleAcademicpeer-review

TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits

Diogo, D., Bastarache, L., Liao, K. P., Graham, R. R., Fulton, R. S., Greenberg, J. D., Eyre, S., Bowes, J., Cui, J., van der Lee, A., Pappas, D. A., Kremer, J. M., Barton, A., Coenen, M. J. H., Franke, B., Kiemeney, L. A., Mariette, X., Richard-Miceli, C., Canhao, H., Fonseca, J. E. & 34 othersde Vries, N., Tak, P. P., Crusius, J. B. A., Nurmohamed, M. T., Kurreeman, F., Mikuls, T. R., Okada, Y., Stahl, E. A., Larson, D. E., Deluca, T. L., O'Laughlin, M., Fronick, C. C., Fulton, L. L., Kosoy, R., Ransom, M., Bhangale, T. R., Ortmann, W., Cagan, A., Gainer, V., Karlson, E. W., Kohane, I., Murphy, S. N., Martin, J., Zhernakova, A., Klareskog, L., Padyukov, L., Worthington, J., Mardis, E. R., Seldin, M. F., Gregersen, P. K., Behrens, T., Raychaudhuri, S., Denny, J. C. & Plenge, R. M., 2015, In : PLoS ONE. 10, 4, e0122271.

Research output: Contribution to journalArticleAcademicpeer-review

2014

Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis

van Denderen, J. C., Visman, I. M., Nurmohamed, M. T., Suttorp-Schulten, M. S. A. & van der Horst-Bruinsma, I. E., 2014, In : Journal of Rheumatology. 41, 9, p. 1843-1848

Research output: Contribution to journalArticleAcademicpeer-review

Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

Vogelzang, E. H., Kneepkens, E. L., Nurmohamed, M. T., van Kuijk, A. W. R., Rispens, T., Wolbink, G. & Krieckaert, C. L. M., 2014, In : Annals of the Rheumatic Diseases. 73, 12, p. 2178-2182

Research output: Contribution to journalArticleAcademicpeer-review

Biologics, cardiovascular effects and cancer

Damjanov, N., Nurmohamed, M. T. & Szekanecz, Z., 2014, In : BMC Medicine. 12, 48.

Research output: Contribution to journalArticleAcademicpeer-review

Biosimilars

Nurmohamed, M. T., 2014, In : Nederlands Tijdschrift voor Reumatologie. 1, p. 28-30

Research output: Contribution to journalArticleProfessional

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Choy, E., Ganeshalingam, K., Semb, A. G., Szekanecz, Z. & Nurmohamed, M. T., 2014, In : Rheumatology. 53, 12, p. 2143-2154

Research output: Contribution to journalArticleAcademicpeer-review

Diastolic left ventricular dysfunction in ankylosing spondylitis-A systematic review and meta-analysis

Heslinga, S. C., Van Dongen, C. J., Konings, T. C., Peters, M. J., van der Horst-Bruinsma, I. E., Smulders, Y. M. & Nurmohamed, M. T., 2014, In : Seminars in Arthritis and Rheumatism. 44, 1, p. 14-19

Research output: Contribution to journalArticleAcademicpeer-review

Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice

Kneepkens, E. L., Plasencia, C., Krieckaert, C. L. M., Pascual-Salcedo, D., van der Kleij, D., Nurmohamed, M. T., Lopez-Casla, M. T., Wieringa, R., Rispens, T. & Wolbink, G., 2014, In : Annals of the Rheumatic Diseases. 73, 12, p. 2217-2219

Research output: Contribution to journalArticleAcademicpeer-review

Is atherosclerosis an autoimmune disease?

Matsuura, E., Atzeni, F., Sarzi-Puttini, P., Turiel, M., Lopez, L. R. & Nurmohamed, M. T., 2014, In : BMC Medicine. 12, 47.

Research output: Contribution to journalArticleAcademicpeer-review

Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?

van Sijl, A. M., van der Weele, W. & Nurmohamed, M. T., 2014, In : Current Pharmaceutical Design. 20, 4, p. 496-499

Research output: Contribution to journalArticleAcademicpeer-review

Niacin for Reduction of Cardiovascular Risk

van den Oever, I. A. M., Nurmohamed, M. T. & Lems, W. F., 2014, In : New England Journal of Medicine. 371, 20, p. 1942-1942

Research output: Contribution to journalArticleAcademicpeer-review

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

Nusslein, H. G., Alten, R., Galeazzi, M., Lorenz, H. M., Boumpas, D., Nurmohamed, M. T., Bensen, W. G., Burmester, G. R., Peter, H. H., Rainer, F., Pavelka, K., Chartier, M., Poncet, C., Rauch, C. & Le Bars, M., 2014, In : BMC Musculoskeletal Disorders. 15, 14.

Research output: Contribution to journalArticleAcademicpeer-review

Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al

Nurmohamed, M. T., Jamnitski, A., Symmons, D., Peters, M. J. L., Sattar, N. & McInnes, I., 2014, In : Annals of the Rheumatic Diseases. 73, 5, p. E28-E28

Research output: Contribution to journalArticleAcademicpeer-review

Rheumatoid arthritis and metabolic syndrome

Kerekes, G., Nurmohamed, M. T., Gonzalez-Gay, M. A., Seres, I., Paragh, G., Kardos, Z., Barath, Z., Tamasi, L., Soltesz, P. & Szekanecz, Z., 2014, In : Nature Reviews Rheumatology. 10, 11, p. 691-696

Research output: Contribution to journalArticleAcademicpeer-review

Statine stoppen bij start colchine?

Agca, R., Turk, S., Jansen, D., Turkstra, F., Gerritsen, M. & Nurmohamed, M. T., 2014, In : Nederlands Tijdschrift voor Reumatologie. 2, p. 9-16

Research output: Contribution to journalArticleProfessional

Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system

van den Oever, I. A. M., Sattar, N. & Nurmohamed, M. T., 2014, In : Annals of the Rheumatic Diseases. 73, 6, p. 954-957

Research output: Contribution to journalArticleAcademicpeer-review

2013

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review

Jamnitski, A., Symmons, D., Peters, M. J. L., Sattar, N., MciInnes, I. & Nurmohamed, M. T., 2013, In : Annals of the Rheumatic Diseases. 72, 2, p. 211-216

Research output: Contribution to journalArticleAcademicpeer-review

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?

Peters, M. J. L. & Nurmohamed, M. T., 2013, In : Arthritis Research & Therapy. 15, 2, 111.

Research output: Contribution to journalArticleAcademicpeer-review

Changes in BMD during longterm treatment with adalimumab in RA

Krieckaert, C. L., Nurmohamed, M. T., Wolbink, G. & Lems, W. F., 2013, In : British Journal of Rheumatology.

Research output: Contribution to journalArticleAcademicpeer-review

Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study

Krieckaert, C. L. M., Nurmohamed, M. T., Wolbink, G. & Lems, W. F., 2013, In : Rheumatology. 52, 3, p. 547-553

Research output: Contribution to journalArticleAcademicpeer-review

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman, S., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Baanstra, D., Kvamme, A. M., Friedman, J., Nurmohamed, M. T., Mismetti, P. & Goldhaber, S. Z., 2013, In : New England Journal of Medicine. 368, 8, p. 709-718

Research output: Contribution to journalArticleAcademicpeer-review

High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study

Jamnitski, A., Levels, J. H., van den Oever, I. A. & Nurmohamed, M. T., 2013, In : Journal of Rheumatology. 40, 6, p. 825-830

Research output: Contribution to journalArticleAcademicpeer-review

Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study

Ursum, J., Nielen, M. M., Twisk, J. W., Peters, M. J., Schellevis, F. G., Nurmohamed, M. T. & Korevaar, J. C., 2013, In : BMC Family Practice. 14, 199.

Research output: Contribution to journalArticleAcademicpeer-review